Caplin Point Laboratories

Company had disseminated a press release containing information on acquisition of ten ANDAs from a Global generic manufacturing company.

01 Jan, 2026 | 11:44am • Source: BSE

Intimation of Closure of Trading window commencing from January 01, 2026.

31 Dec, 2025 | 06:31pm • Source: BSE

We enclose herewith the Notice of Postal Ballot of Caplin Point Laboratories Limited seeking the approval of members for the resolutions mentioned in the Notice.

31 Dec, 2025 | 03:24pm • Source: BSE

Press Release on the company''s Subsidiary, Caplin Steriles Limited, getting USFDA approval for its ANDA Linezolid Injection 600 mg/ 300 mL (2 mg/mL) Single Dose...

09 Dec, 2025 | 01:57pm • Source: BSE

Press Release regarding receipt of final approval by our Subsidiary, Caplin Steriles Limited from USFDA for ANDA Acetaminophen Injection, 1000 mg/100 mL (10 mg/ mL)...

08 Dec, 2025 | 03:36pm • Source: BSE

Acquisition of land by Subsidiary at Mexico

14 Nov, 2025 | 05:19pm • Source: BSE

Transcript of the Earnings Call - Q2 & H1 FY 2025-26

12 Nov, 2025 | 06:49pm • Source: BSE

Results - Analyst/Investor Meet - Earnings Call - Q2(2025-2026) - Audio Recording

06 Nov, 2025 | 06:29pm • Source: BSE

Appointment of Directors of the Company

05 Nov, 2025 | 04:26pm • Source: BSE

Change in Senior Managerial Personnel of the Company

05 Nov, 2025 | 04:23pm • Source: BSE

Un-audited standalone and consolidated financial results for the quarter and half year ended 30th September 2025

05 Nov, 2025 | 01:49pm • Source: BSE

Outcome of the Board Meeting

05 Nov, 2025 | 01:41pm • Source: BSE

Caplin Point Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2025 ,inter alia, to consider...

29 Oct, 2025 | 07:12pm • Source: BSE

Analyst / investor Call for the quarter and half ended September 30, 2025

29 Oct, 2025 | 06:40pm • Source: BSE

Caplin Point Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 ,inter alia, to consider...

29 Oct, 2025 | 06:33pm • Source: BSE

Intimation pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018

04 Oct, 2025 | 02:03pm • Source: BSE

Closure of Trading Window

29 Sep, 2025 | 04:44pm • Source: BSE

Caplin Point Laboratories Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial...

29 Sep, 2025 | 03:14pm • Source: NSE

Voting Results and Scrutinizer Report for the 34th Annual General Meeting

23 Sep, 2025 | 06:11pm • Source: BSE

Intimation of Appointment of Secretarial Auditor of the Company

22 Sep, 2025 | 05:04pm • Source: BSE